da Silva Rondineli Mendes, Caetano Rosangela
Escola Nacional de Saúde Pública Sérgio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil,
Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Brasil.
Cien Saude Colet. 2015 Oct;20(10):2943-56. doi: 10.1590/1413-812320152010.17352014.
The "Farmácia Popular do Brasil" Program (PFPB) aims to improve access to medicines, offering subsidized products. It is structured in an arrangement involving public and private sectors. The paper described the organization and expansion of the PFPB and examined the reference price (RP) of the medicines paid by the government, between 2004 and 2012. It is an exploratory study of quantitative and qualitative approach, developed from the literature review and analysis of public documents. Quantitative data were collected from the Ministry of Health and Electronic System of Citizens Information Services. The PFPB is organized in two delivery models: public owned facilities (Rede Própria) and accredited private retail pharmacies (Aqui Tem Farmácia Popular-ATFP). The ATFP has allowed its own expansion, from 2006. Antihypertensives, antidiabetics and antiasthmatics were exempt from copayment, since 2011. The expansion of the ATFP Program was significant, for facilities and covered municipalities, 750% and 528%, respectively. The RP was reduced by 33.6% on average (ranging from 23-52%) for medicines available since the beginning of the ATFP. The expansion was performed with the actions hitherto unprecedented, as copayment and accreditation of private retail pharmacies.
巴西大众药房计划（PFPB）旨在通过提供补贴药品来改善药品可及性。该计划采用了一种涉及公共部门和私营部门的架构。本文描述了PFPB的组织与扩张情况，并研究了2004年至2012年期间政府支付药品的参考价格（RP）。这是一项采用定量和定性方法的探索性研究，基于文献综述和公共文件分析开展。定量数据收集自卫生部和公民信息服务电子系统。PFPB采用两种配送模式：公有设施（自有网络）和经认证的私营零售药店（这里有大众药房 - ATFP）。自2006年起，ATFP实现了自身的扩张。自2011年起，抗高血压药、抗糖尿病药和抗哮喘药无需自付费用。就设施数量和覆盖的城市数量而言，ATFP计划的扩张幅度分别高达750%和528%，十分显著。自ATFP启动以来，现有药品的RP平均降低了33.6%（降幅在23%至52%之间）。此次扩张是通过诸如自付费用和私营零售药店认证等前所未有的举措实现的。
